Nasdaq expects GlobeImmune IPO Friday

LOUISVILLE – Biopharmaceutical company GlobeImmune Inc.’s initial public offering is expected to occur Friday, June 27, according to the Nasdaq exchange’s online rundown of upcoming IPOs.

The Louisville-based company initially filed for the IPO in March, but reduced the amount of shares offered in May from nearly 2.2 million to 1,562,500.

Pricing is expected to be in the $15 to $17 range, meaning the offering could be worth a little more than $30 million at the high end of the range if over-allotted shares are included. The company will list on the Nasdaq exchange under the ticker symbol GBIM.

The company has said it would use proceeds from the offering to continue clinical trials and prepare its manufacturing plant for clinical trial and commercial scale manufacturing.

Founded in the mid-1990s as a spinoff of University of Colorado research, GlobeImmune has about 25 employees, and is based at 1450 Infinite Drive, in Louisville.

GlobeImmune filed for an IPO a year ago seeking to raise $69 million, but withdrew the plans in October. In February, the company raised $7.5 million through SternAegis Ventures, an arm of Aegis Capital Corp. in New York. Aegis Capital is the lone book runner for the current IPO.

GlobeImmune is developing drugs to treat pancreatic cancer and hepatitis B and C along with other research products.


Comments

Advertising
Advertising
Advertising

Assessed Valuations

FacebookTwitterLinkedInE-mail Here’s a question we hear from customers quite often: When will rates go up and what happens when they

Custom Publications

Awards

  • Awards – 02/28/2014

    FacebookTwitterLinkedInE-mail Boulder-based Clean Energy Collective received the Most Innovative Solar Company award from Solar Power Generation USA. Clean Energy develops

  • Awards – 02/14/2014

    FacebookTwitterLinkedInE-mail Lafayette-based The Creative Alliance won an American Package Design Award from GD USA Magazine for packaging designed for its

  • Awards – 01/31/2014

    FacebookTwitterLinkedInE-mail Two University of Colorado-Boulder researchers were among 15 honored week by the National Academy of Sciences for extraordinary scientific

RSS

RSS

RSS

RSS

RSS

Advertising

Social Network

 
Facebook Icon
Twitter Icon
LinkedIn Icon